World News: 13:01 GMT Friday 9th November 2018. [Atea Pharmaceuticals, Inc. via Globe Newswire via SPi World News]
BOSTON Nov 09 2018 GLOBE NEWSWIRE -- Atea Pharmaceuticals Inc a biopharmaceutical company engaged in the development of next-generation therapeutics for the treatment of hepatitis C and other single stranded RNA viral infections today ann ounced ...
Globe Newswire: 13:01 GMT Friday 9th November 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.